Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prevalence of high-risk human papillomavirus DNA and mRNA and its association with abnormal anal cytology in the Czech male anal cancer screening cohort

J. Nemcova, K. Cerna, F. Rob, J. Smahelova, J. Tresnak Hercogova, J. Marx, I. Traxmandlova, O. Ondic

. 2021 ; 49 (11) : 1188-1195. [pub] 20210916

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011976

Grantová podpora
AZV17-31777A Ministry of Health of the Czech Republic

BACKGROUND: Anal cancer (AC) screening is justified in high-risk populations, particularly HIV-positive men having sex with men (MSM). HR-HPV testing could improve the efficiency of cytologically based screening of AC, as in the screening of biologically analogical cervical cancer. The specificity of HR-HPV testing is influenced by the prevalence of HR-HPV infection in the screened population. Reported anal HR-HPV DNA prevalence in MSM is high, but HR-HPV mRNA reflects rather long-term infections and is more specific for high-grade lesions. However, no data were published about HR-HPV DNA and mRNA prevalence in the Czech AC screening population. METHOD: Results of liquid-based anal cytology of 203 predominantly HIV-positive MSM from the Czech AC screening cohort were correlated with results of DNA and E6/E7 mRNA testing of 14 HR-HPV types, and HPV16 genotyping. Eighty-one MSM underwent a standard anoscopy. RESULTS: A total of 109 (53.7%) samples had abnormal cytology, with 12 (5.9%) ASC-H/HSIL, 67 (33.0%) samples cytologically negative, and 27 (13.3%) unsatisfactory. HR-HPV DNA was detected in 134 (66.0%) and HR-HPV RNA in 72 (35.5%) anal smears. HR-HPV mRNA and HPV16 mRNA positivity were associated with abnormal cytology (p = .0037, p = .0021). No significant association was found between HR-HPV DNA or HPV16 DNA positivity and abnormal cytology. No high-grade lesions were revealed by anoscopy. CONCLUSION: Prevalence of anal HR-HPV DNA among Czech MSM is high, however, the prevalence of HR-HPV mRNA is half and associated with abnormal cytology. Our results indicate an increased efficiency of cytological screening when combined with HR-HPV mRNA testing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011976
003      
CZ-PrNML
005      
20220506125847.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/dc.24873 $2 doi
035    __
$a (PubMed)34529895
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nemcova, Jana $u Biomedical Center of the Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Sikl's Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic $u Biopticka Laborator s.r.o., Pilsen, Czech Republic $1 https://orcid.org/000000032855653X
245    10
$a Prevalence of high-risk human papillomavirus DNA and mRNA and its association with abnormal anal cytology in the Czech male anal cancer screening cohort / $c J. Nemcova, K. Cerna, F. Rob, J. Smahelova, J. Tresnak Hercogova, J. Marx, I. Traxmandlova, O. Ondic
520    9_
$a BACKGROUND: Anal cancer (AC) screening is justified in high-risk populations, particularly HIV-positive men having sex with men (MSM). HR-HPV testing could improve the efficiency of cytologically based screening of AC, as in the screening of biologically analogical cervical cancer. The specificity of HR-HPV testing is influenced by the prevalence of HR-HPV infection in the screened population. Reported anal HR-HPV DNA prevalence in MSM is high, but HR-HPV mRNA reflects rather long-term infections and is more specific for high-grade lesions. However, no data were published about HR-HPV DNA and mRNA prevalence in the Czech AC screening population. METHOD: Results of liquid-based anal cytology of 203 predominantly HIV-positive MSM from the Czech AC screening cohort were correlated with results of DNA and E6/E7 mRNA testing of 14 HR-HPV types, and HPV16 genotyping. Eighty-one MSM underwent a standard anoscopy. RESULTS: A total of 109 (53.7%) samples had abnormal cytology, with 12 (5.9%) ASC-H/HSIL, 67 (33.0%) samples cytologically negative, and 27 (13.3%) unsatisfactory. HR-HPV DNA was detected in 134 (66.0%) and HR-HPV RNA in 72 (35.5%) anal smears. HR-HPV mRNA and HPV16 mRNA positivity were associated with abnormal cytology (p = .0037, p = .0021). No significant association was found between HR-HPV DNA or HPV16 DNA positivity and abnormal cytology. No high-grade lesions were revealed by anoscopy. CONCLUSION: Prevalence of anal HR-HPV DNA among Czech MSM is high, however, the prevalence of HR-HPV mRNA is half and associated with abnormal cytology. Our results indicate an increased efficiency of cytological screening when combined with HR-HPV mRNA testing.
650    _2
$a dospělí $7 D000328
650    _2
$a nádory anu $x genetika $x patologie $7 D001005
650    _2
$a DNA virů $x genetika $7 D004279
650    _2
$a časná detekce nádoru $x statistika a číselné údaje $7 D055088
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a homosexualita mužská $x genetika $x statistika a číselné údaje $7 D018451
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a infekce papilomavirem $x epidemiologie $x patologie $x virologie $7 D030361
650    _2
$a prevalence $7 D015995
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a sexuální a genderové menšiny $x statistika a číselné údaje $7 D000072339
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cerna, Katerina $u Biomedical Center of the Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Sikl's Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic $u Biopticka Laborator s.r.o., Pilsen, Czech Republic
700    1_
$a Rob, Filip $u Department of Dermatovenereology, Second Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic
700    1_
$a Smahelova, Jana $u National Reference Laboratory for Papillomaviruses and Polyomaviruses, Institute Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Tresnak Hercogova, Jana $u Department of Dermatovenereology, Second Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic
700    1_
$a Marx, Josef $u Department of Surgery, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic
700    1_
$a Traxmandlova, Iva $u Faculty of Education, Centre for Biology, Geoscience and Environmental Education, University of West Bohemia, Pilsen, Czech Republic $u Global Change Research Institute, Czech Academy of Science, Brno, Czech Republic
700    1_
$a Ondic, Ondrej $u Biomedical Center of the Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Sikl's Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic $u Biopticka Laborator s.r.o., Pilsen, Czech Republic
773    0_
$w MED00001393 $t Diagnostic cytopathology $x 1097-0339 $g Roč. 49, č. 11 (2021), s. 1188-1195
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34529895 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125839 $b ABA008
999    __
$a ok $b bmc $g 1789523 $s 1163177
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 49 $c 11 $d 1188-1195 $e 20210916 $i 1097-0339 $m Diagnostic cytopathology $n Diagn Cytopathol $x MED00001393
GRA    __
$a AZV17-31777A $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace